Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study

Abstract

One-year treatment according to T2T strategy significantly improves all PsA clinical domains - arthritis, dactylitis, enthesitis, skin psoriasis and quality of life despite of type of treatment. It seems that T2T is a useful strategy in EPsA but additional research concerning its implementation in real practice are needed.